≡ Risteys
R8

Documentation Changelog GitHub Contact & Feedback

L02BX Other hormone antagonists and related agents

PheWeb

RX_L02BX

No definition available.

Endpoint definition

↥
FinnGen phenotype data

356077 individuals

diagram downward connector

Apply sex-specific rule None

356077

diagram downward connector

Check conditions None

356077

diagram downward connector
diagram bullet

Filter registries

Medicine purchases: ATC L02BX

1027

diagram downward connector

Check pre-conditions, main-only, mode, ICD version None

822

diagram downward connector
diagram bullet

Check minimum number of events

Min. number of events 3

822

diagram downward connector

Include endpoints None

822

diagram downward connector
RX_L02BX

Extra metadata

First used in FinnGen datafreeze DF3

Summary Statistics

↥

Key figures

All Female Male
Number of individuals 822 - 822
Unadjusted prevalence (%) 0.23 - 0.52
Mean age at first event (years) 72.56 - 72.56

Mortality

Follow-up Absolute risk HR [95% CI] p N
1998–2019 - - - -
15 years - - - -
5 years - - - -
1 year - - - -

Age distribution of first events

Year distribution of first events

Cumulative Incidence

Correlations

↥

Index endpoint: RX_L02BX – L02BX Other hormone antagonists and related agents
GWS hits:

Survival analyses between endpoints

↥

Plot

before L02BX Other hormone antagonists and related agents
after L02BX Other hormone antagonists and related agents

loading spinner Loading survival analyses plot

Drugs most likely to be purchased after L02BX Other hormone antagonists and related agents

↥